Research suggests that topically applied peppermint-derived menthol shows some promise for headache and migraine relief, with one small randomized controlled trial finding that a 10% menthol solution applied to the forehead and temples outperformed a low-dose placebo on multiple pain and symptom measures during active migraine attacks. The available evidence base, however, is quite limited — the supporting trial involved only 35 participants across a single center, and the other studies included in this review examined unrelated treatments such as aspirin for tension-type headache and a triptan medication for migraine, neither of which directly addresses peppermint. Studies indicate that drawing broad conclusions from a single small trial is difficult, and the field would benefit from larger, more rigorously designed studies before the strength of this evidence can be meaningfully assessed. As it stands, the research is preliminary and directionally encouraging but not definitive.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Aspirin for acute treatment of episodic tension-type headache in adults. | Meta-analysis | 2017 | Neutral | 72 |
| Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine. | RCT | 2000 | Neutral | 67 |
| Cutaneous application of menthol 10% solution as an abortive treatment of mig... | RCT | 2010 | Supports | 62 |